Literature DB >> 24011785

Cumulative exposure to paternal seminal fluid prior to conception and subsequent risk of preeclampsia.

Audrey F Saftlas1, Linda Rubenstein1, Kaitlin Prater2, Karisa K Harland3, Elizabeth Field4, Elizabeth W Triche5.   

Abstract

A growing body of literature suggests that prior and prolonged exposure to paternal antigens in seminal fluid induces maternal tolerance to the allogeneic fetus, protecting it from rejection and facilitating successful implantation and placentation. In this case-control study of nulliparous women, we test the hypothesis that increased exposure to paternal seminal fluid via the vaginal or oral route will confer a reduced risk of preeclampsia. Preeclampsia cases (n=258) and normotensive controls (n=182) were selected from live births to Iowa women over the period August 2002 to April 2005. Disease status was verified by medical chart review. Seminal fluid exposure indexes incorporated information on type and frequency of sexual practices, contraceptive use, and ingestion practices prior to conception with the baby's father. Preeclampsia risk decreased significantly with increasing vaginal exposure to paternal semen (test for trend p<0.05). Women in the highest 10th percentile of vaginal exposure had a 70% reduced odds of preeclampsia relative to women in the lowest 25th percentile of exposure (aOR=0.3; 95% CI: 0.1-0.9). Oral seminal fluid exposure was not associated with a reduced risk of preeclampsia. These findings are congruent with the immune maladaptation hypothesis of preeclampsia causation and indicate that paternal antigen exposure via the vaginal mucosa may facilitate immune tolerance to paternal HLA. Thus, advising nulliparous women to decrease their use of barrier contraceptive methods and to increase vaginal sexual intercourse prior to conceiving may reduce their risk of preeclampsia.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Epidemiology; Immunology; Paternity; Preeclampsia; Seminal fluid; Sperm

Mesh:

Substances:

Year:  2013        PMID: 24011785     DOI: 10.1016/j.jri.2013.07.006

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  34 in total

Review 1.  Maternal immunity and pregnancy outcome: focus on preconception and autophagy.

Authors:  G Sisti; T T Kanninen; S S Witkin
Journal:  Genes Immun       Date:  2015-12-10       Impact factor: 2.676

2.  The impact of using donor sperm in assisted reproductive technology cycles on perinatal outcomes.

Authors:  Bo Yu; Rani Fritz; Xianhong Xie; Abdissa Negassa; Sangita Jindal; Mario Vega; Erkan Buyuk
Journal:  Fertil Steril       Date:  2018-12       Impact factor: 7.329

3.  Correlative research of the incidence of preeclampsia and sperm exposure.

Authors:  Dibing Zhu; Yang Song; Qingqing Ding; Cuicui Duan; Wei Wu; Jian Xu
Journal:  Arch Gynecol Obstet       Date:  2021-05-23       Impact factor: 2.344

4.  Physical Activity During Pregnancy and Subsequent Risk of Preeclampsia and Gestational Hypertension: A Case Control Study.

Authors:  Cassandra N Spracklen; Kelli K Ryckman; Elizabeth W Triche; Audrey F Saftlas
Journal:  Matern Child Health J       Date:  2016-06

5.  Genetic Risk Score for Essential Hypertension and Risk of Preeclampsia.

Authors:  Caitlin J Smith; Audrey F Saftlas; Cassandra N Spracklen; Elizabeth W Triche; Andrew Bjonnes; Brendan Keating; Richa Saxena; Patrick J Breheny; Andrew T Dewan; Jennifer G Robinson; Josephine Hoh; Kelli K Ryckman
Journal:  Am J Hypertens       Date:  2015-05-23       Impact factor: 2.689

Review 6.  Preeclampsia: What Does the Father Have to Do with It?

Authors:  V Katsi; I Felekos; C Siristatidis; S Kasioni; A Drakontaidis; G Farmakides; T Makris; C Aggeli; P Nihoyannopoulos; D Tousoulis; I Kallikazaros
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

Review 7.  Regulatory T cells in embryo implantation and the immune response to pregnancy.

Authors:  Sarah A Robertson; Alison S Care; Lachlan M Moldenhauer
Journal:  J Clin Invest       Date:  2018-10-01       Impact factor: 14.808

Review 8.  Preeclampsia and health risks later in life: an immunological link.

Authors:  Shi-Bin Cheng; Surendra Sharma
Journal:  Semin Immunopathol       Date:  2016-06-23       Impact factor: 9.623

Review 9.  Maternal-fetal cross talk through cell-free fetal DNA, telomere shortening, microchimerism, and inflammation.

Authors:  Shi-Bin Cheng; Sarah Davis; Surendra Sharma
Journal:  Am J Reprod Immunol       Date:  2018-03-25       Impact factor: 3.886

10.  Genetic predisposition to elevated levels of C-reactive protein is associated with a decreased risk for preeclampsia.

Authors:  Cassandra N Spracklen; Caitlin J Smith; Audrey F Saftlas; Elizabeth W Triche; Andrew Bjonnes; Brendan J Keating; Richa Saxena; Patrick J Breheny; Andrew T Dewan; Jennifer G Robinson; Josephine Hoh; Kelli K Ryckman
Journal:  Hypertens Pregnancy       Date:  2016-09-22       Impact factor: 2.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.